We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

Back to rankings

213 hedge funds and large institutions have $5.11B invested in Loxo Oncology, Inc in 2018 Q2 according to their latest regulatory filings, with 66 funds opening new positions, 67 increasing their positions, 62 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

560% more first-time investments, than exits

New positions opened: 66 | Existing positions closed: 10

54% more call options, than puts

Call options by funds: $50M | Put options by funds: $32.5M

41% more capital invested

Capital invested by funds: $3.61B → $5.11B (+$1.49B)

35% more funds holding

Funds holding: 158 → 213 (+55)

8% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 62

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

Holders
213
Holders Change
+55
Holders Change %
+34.81%
% of All Funds
4.88%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
66
Increased
67
Reduced
62
Closed
10
Calls
$50M
Puts
$32.5M
Net Calls
+$17.5M
Net Calls Change
+$35.6M

Top Buyers

Rank Fund Capital Flow
1
Fidelity International
Fidelity International
Bermuda
+$88.8M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$47.7M
3
MWNA
Marshall Wace North America
New York
+$46.3M
4
BlackRock
BlackRock
New York
+$42.1M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$41.2M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$306M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$103M
3
O
OrbiMed
New York
-$60.6M
4
BC
Boxer Capital
California
-$46.1M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$31.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
126
Bank of Montreal
Ontario, Canada
$1.42M +$1.1M +7,298 +851%
EAMA
127
EFG Asset Management (Americas)
Florida
$1.41M +$1.22M +8,148 New
FAM
128
Fred Alger Management
New York
$1.39M +$1.2M +8,000 New
MSL
129
Mackay Shields LLC
New York
$1.28M -$180K -1,200 -14%
OPPM
130
Opus Point Partners Management
New York
$1.2M – – –
Barclays
131
Barclays
United Kingdom
$1.16M -$393K -2,617 -28%
DCM
132
Dupont Capital Management
Delaware
$1.1M +$450K +2,993 +90%
PA
133
Pinnacle Associates
New York
$1.06M -$887K -5,905 -49%
Mirae Asset Global Investments
134
Mirae Asset Global Investments
South Korea
$991K +$858K +5,712 New
Capital Fund Management (CFM)
135
Capital Fund Management (CFM)
France
$978K +$847K +5,638 New
Los Angeles Capital Management
136
Los Angeles Capital Management
California
$957K +$150K +1,000 +22%
Teacher Retirement System of Texas
137
Teacher Retirement System of Texas
Texas
$789K -$13.1K -87 -2%
Lazard Asset Management
138
Lazard Asset Management
New York
$788K – – –
VEA
139
Virtus ETF Advisers
New York
$787K -$723K -4,811 -51%
JMPWA
140
JP Morgan Private Wealth Advisors
California
$756K +$1.05K +7 +0.2%
SG Americas Securities
141
SG Americas Securities
New York
$752K +$415K +2,760 +176%
TAM
142
Tocqueville Asset Management
New York
$711K +$11.3K +75 +2%
BI
143
BVF Inc
California
$709K -$44.6K -297 -7%
AB
144
Amalgamated Bank
New York
$703K +$151K +1,002 +33%
Squarepoint
145
Squarepoint
New York
$677K +$586K +3,900 New
PA
146
Perceptive Advisors
New York
$653K +$566K +3,765 New
WG
147
Winton Group
United Kingdom
$631K -$705K -4,688 -56%
Allianz Asset Management
148
Allianz Asset Management
Germany
$612K +$530K +3,525 New
PVAM
149
Pacific View Asset Management
California
$608K +$526K +3,502 New
JRP
150
Jasper Ridge Partners
California
$600K – – –
4 5
6
7 8

LOXO Hedge Fund Activity: Q2 2018 in Review

213 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q2 2018, worth a combined $5.11B — up 41% from $3.61B a quarter earlier.

Buyers outnumbered sellers: 66 funds opened new LOXO positions and 10 closed out — a net gain of 56 holders — while 67 added to existing stakes and 62 trimmed.

The largest buyer was Fidelity International, opening a new position worth an estimated $88.8M. The largest seller was Fidelity Investments, cutting an estimated $306M.

  • 213 institutional investors held Loxo Oncology, Inc (LOXO) as of Q2 2018, up from 158 in Q1 2018.
  • Funds reported $5.11B of Loxo Oncology, Inc stock for Q2 2018, up 41% quarter-over-quarter.
  • 66 funds opened new Loxo Oncology, Inc positions in Q2 2018 and 10 closed out, a net change of +56 holders.
  • The largest Loxo Oncology, Inc buyer in Q2 2018 was Fidelity International, an estimated $88.8M added.
  • The largest Loxo Oncology, Inc seller in Q2 2018 was Fidelity Investments, an estimated $306M sold.

Based on aggregated 13F filings for Q2 2018.